Finance

Lists
Outlook: 22.2% bullish·38.1% bearish
Go to analysis
HIMS:NYSE
Hims & Hers Health Inc
19,73 US$
+0,05%
(+0,010) 1D
19,19 US$
-2,74% (-0,54)
Pre-market
Closed: 13 ნოე, 16:00:04 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
19,68 US$
High
20,16 US$
Low
19,18 US$
Mkt. cap
4,62 მლრდ.
Avg. vol.
13,79 მლნ.
Volume
49,82 ათ.
52-wk high
40,99 US$
52-wk low
13,74 US$
EPS
-0,83 US$
Beta
2,53
Shares outstanding
226,04 მლნ.
No. of employees
2 ათ.
Open
19,68 US$
High
20,16 US$
Low
19,18 US$
Mkt. cap
4,62 მლრდ.
Avg. vol.
13,79 მლნ.
Volume
49,82 ათ.
52-wk high
40,99 US$
52-wk low
13,74 US$
EPS
-0,83 US$
Beta
2,53
Shares outstanding
226,04 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees2,44 ათ.
Foundedნოე 2017
Headquartersსან-ფრანცისკო, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryHealth care provider
Website-
Analyst ratings
Based on 12 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
9
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current 19,73 US$
40,00 US$ (+102,74%)
Average
29,22 US$ (+48,10%)
Lowest
24,00 US$ (+21,64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Justin Patterson
KeyBanc
Hold
Maintained
-
-
11/11/2026
Allen Lutz
Bank of America Securities
Hold
Maintained
-
-
11/10/2026
Michael Cherny
Leerink Partners
Hold
Maintained
24,00 US$
+21,6%
11/10/2026
Bryan Smilek
J.P. Morgan
Hold
Maintained
24,00 US$
+21,6%
11/10/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
27,00 US$
+36,8%
11/10/2026
Brian Tanquilut
Jefferies
Hold
Maintained
24,00 US$
+21,6%
11/10/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
25,00 US$
+26,7%
11/10/2026
Ryan MacDonald
Needham
Buy
Reiterated
32,00 US$
+62,2%
11/10/2026
Maria Ripps
Canaccord Genuity
Buy
Maintained
40,00 US$
+102,7%
11/10/2026
David Larsen
BTIG
Hold
Maintained
-
-
11/09/2026
Glen Santangelo
Barclays
Buy
Maintained
35,00 US$
+77,4%
11/10/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
32,00 US$
+62,2%
09/11/2026
George Hill
Deutsche Bank
Hold
Reiterated
26,00 US$
+31,8%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
30,00 US$
+52,1%
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
33,00 US$
+67,3%
08/12/2026
Oliver Chen
TD Cowen
Hold
Reiterated
25,00 US$
+26,7%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
33,00 US$
+67,3%
05/12/2026
Unknown Analyst
Nephron
Buy
Upgraded
35,00 US$
+77,4%
03/09/2026
Last report
10 ნოე. 2026
Fiscal period
Q3 2026
0,03 US$ / 0,15 US$
-81,97%miss
Revenue / Est. (USD)
890,37 მლნ. / 892,77 მლნ.
-0,27%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
617,82 მლნ.
608,10 მლნ.
753,21 მლნ.
890,37 მლნ.
Cost of goods sold
173,38 მლნ.
182,82 მლნ.
272,41 მლნ.
381,17 მლნ.
Cost of revenue
173,38 მლნ.
182,82 მლნ.
272,41 მლნ.
381,17 მლნ.
Research and development expenses
40,96 მლნ.
46,94 მლნ.
54,90 მლნ.
69,39 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
386,64 მლნ.
426,37 მლნ.
521,95 მლნ.
505,96 მლნ.
Operating expense
427,60 მლნ.
473,31 მლნ.
576,85 მლნ.
575,34 მლნ.
Total operating expenses
600,99 მლნ.
656,13 მლნ.
849,26 მლნ.
956,52 მლნ.
Operating income
16,83 მლნ.
-48,02 მლნ.
-96,04 მლნ.
-66,15 მლნ.
Other non operating income
1,82 მლნ.
-18,58 მლნ.
-2,43 მლნ.
-514,00 ათ.
EBT including unusual items
18,35 მლნ.
-101,55 მლნ.
-92,63 მლნ.
-46,25 მლნ.
EBT excluding unusual items
21,56 მლნ.
-61,57 მლნ.
-96,22 მლნ.
-67,36 მლნ.
Income tax expense
-2,25 მლნ.
-9,44 მლნ.
-6,34 მლნ.
-13,21 მლნ.
Effective tax rate
-12,25%
9,29%
6,85%
28,56%
Other operating expenses
-
-
-
-
Net income
20,60 მლნ.
-92,12 მლნ.
-86,29 მლნ.
-33,04 მლნ.
Net profit margin
3,33%
-15,15%
-11,46%
-3,71%
Earnings per share
0,22
-0,19
-0,09
0,03
Interest and investment income
3,83 მლნ.
7,90 მლნ.
6,00 მლნ.
4,80 მლნ.
Interest expense
-921,00 ათ.
-2,87 მლნ.
-3,75 მლნ.
-5,50 მლნ.
Net interest expenses
2,90 მლნ.
5,03 მლნ.
2,25 მლნ.
-702,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
34,92 მლნ.
-26,07 მლნ.
-66,57 მლნ.
-27,94 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები